Trade Mind Medicine (MindMed) Inc. Subordinate Voting Shares - MNMD CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.09 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.01 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.98 |
| Open | 6.76 |
| 1-Year Change | 83.7% |
| Day's Range | 6.75 - 6.95 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jan 24, 2025 | 6.98 | -0.05 | -0.71% | 7.03 | 7.26 | 6.92 |
| Jan 23, 2025 | 7.17 | 0.36 | 5.29% | 6.81 | 7.22 | 6.79 |
| Jan 22, 2025 | 6.99 | -0.01 | -0.14% | 7.00 | 7.20 | 6.76 |
| Jan 21, 2025 | 7.17 | -0.03 | -0.42% | 7.20 | 7.45 | 7.02 |
| Jan 17, 2025 | 7.14 | 0.65 | 10.02% | 6.49 | 7.26 | 6.37 |
| Jan 16, 2025 | 6.50 | -0.11 | -1.66% | 6.61 | 6.75 | 6.38 |
| Jan 15, 2025 | 6.74 | 0.51 | 8.19% | 6.23 | 7.01 | 6.22 |
| Jan 14, 2025 | 6.38 | -0.13 | -2.00% | 6.51 | 6.53 | 6.20 |
| Jan 13, 2025 | 6.49 | -0.17 | -2.55% | 6.66 | 6.74 | 6.29 |
| Jan 10, 2025 | 6.90 | 0.07 | 1.02% | 6.83 | 6.94 | 6.59 |
| Jan 8, 2025 | 7.04 | -0.94 | -11.78% | 7.98 | 7.99 | 6.91 |
| Jan 7, 2025 | 8.04 | 0.08 | 1.01% | 7.96 | 8.79 | 7.90 |
| Jan 6, 2025 | 7.63 | 0.43 | 5.97% | 7.20 | 7.82 | 7.10 |
| Jan 3, 2025 | 7.14 | -0.40 | -5.31% | 7.54 | 7.83 | 7.06 |
| Jan 2, 2025 | 7.51 | 0.58 | 8.37% | 6.93 | 7.56 | 6.93 |
| Dec 31, 2024 | 6.94 | 0.24 | 3.58% | 6.70 | 6.96 | 6.37 |
| Dec 30, 2024 | 6.69 | 0.14 | 2.14% | 6.55 | 6.70 | 6.35 |
| Dec 27, 2024 | 6.82 | -0.64 | -8.58% | 7.46 | 7.74 | 6.56 |
| Dec 26, 2024 | 7.60 | 0.45 | 6.29% | 7.15 | 7.64 | 6.90 |
| Dec 24, 2024 | 7.26 | 0.24 | 3.42% | 7.02 | 7.33 | 6.83 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Mind Medicine (MindMed) Company profile
Mind Medicine (MindMed) Inc is a biopharmaceutical company that develops clinical-stage psychedelic medicines to treat brain health disorders. The New York-based firm specialises in psychiatry, addiction, pain management and neurology.
Founded in May 2019, MindMed has several drug candidates targeting serotonin, dopamine and acetylcholine systems. These products are based on psychedelic and empathogen substances. The company’s main drug candidate is MM-120, which is a proprietary, pharmaceutically optimised form of LSD. The medication is being developed to treat generalised anxiety disorder (GAD). MindMed is also researching the drug in various dosing regimens for the treatment of attention deficit hyperactivity disorder, also known as attention-deficit/hyperactivity disorder (ADHD), as well as chronic pain.
MM-110, the company’s second advanced drug, is being developed to treat opioid withdrawal. The MM-110, also known by the non-proprietary name zolunicant, is a form of 18-methoxycoronaridine, an ibogaine congener.
The company’s third medicine candidate is MM-402, or R(-)-MDMA, a proprietary form of the R-enantiomer of MDMA (3,4-methylenedioxymethamphetamine). The medicine is being developed for the treatment of core symptoms of autism spectrum disorder.
In addition to its advanced stage drugs, the company also has several earlier stage research programmes through external collaboration, including a multi-year exclusive partnership with University Hospital Basel (UHB) in Switzerland.
MindMed does not own or operate any manufacturing facilities. All clinical and non-clinical materials are supplied by third-party contract manufacturing organisations, or CMOs.
MindMed went public on 27 February 2020 on the Toronto-based NEO Exchange under the ticker ‘MMED’. It is listed on Nasdaq under the symbol ‘MNMD’ and in Germany under the ticker ‘BGHM’.
| Industry: | Biotechnology & Medical Research (NEC) |
One World Trade Center
Suite 8500
NEW YORK
NEW YORK 10007
US
News
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
12:40, 31 December 2024
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com